Ai Ling Tan, Senior Academic at University of Sydney, Member of Gynaecology Oncology Committee at Asia Oceania Federation of Obstetrics and Gynaecology, shared IGCS – International Gynecologic Cancer Society’s post on LinkedIn, adding:
“Delighted to see the Fiji story featured in the upcoming BBC Story Works/UICC Rewriting Cancer series.
This film follows the journey of Fiji’s first formally trained gynaecologic oncologist, Dr. Nanise Sikiti, and current fellow Dr. Unaisi Tabua through the IGCS Global Fellowship Program.
What makes this story special is that it is not really about one person. It is about partnership, mentorship, and building sustainable cancer care within countries and communities.
Nanise’s achievement belongs to Fiji, and her story reflects what is possible when local leadership is supported by long-term commitment and collaboration.
Looking forward to sharing the full film when it launches on 23 June.”
Quoting IGCS – International Gynecologic Cancer Society’s post:
“Cancer is one of the greatest health challenges of our time. But around the world, people are changing the story.
Rewriting Cancer returns with powerful stories of innovation, partnership, and progress – from Fiji (that’s us!) to Argentina and beyond.
IGCS is honored and proud to be part of this global storytelling initiative, presented by UICC and produced for them by BBC Story Works Commercial Productions.
Our film highlights the impact of the IGCS Gynecologic Oncology Global Fellowship Program, which trains physicians in their own countries to become gynecologic cancer specialists. Featuring Dr. Nanise Sikiti, Fiji’s first formally trained gynecologic oncologist, alongside mentor Dr. Ai Ling Tan CNZM and fellow Dr. Unaisi Tabua, the story demonstrates the ripple effect of mentorship and locally led cancer care.
The story may unfold in Fiji, but its spirit lives across all 23 Fellowship training sites and the communities they serve. We cannot wait for you to see it.
Coming June 23.”
Other articles featuring Ai Ling Tan and IGCS on OncoDaily.